<prompt> In pulmonary embolism , fibrinolytic therapy is responsible forMassive emboliRisk of hemorrhageAll the aboveNone of the above  <response>: Hemorrhage is the main complication of fibrinolytic therapy, so it is contraindicated in all situations where the risk of bleeding is increased - recent trauma, surgery, biopsies, stroke, peptic ulcer, aneurysms, bleeding disorders, diabetes, acute pancreatitis etc. 